Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544397/
Cannabis and psychosis: what causes what? (full – 2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544398/
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission
Associated with Olanzapine-Induced Weight Gain (full – 2013)
http://www.plosone.org/article/info%...l.pone.0033548
An investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid
receptor stimulation on prepulse inhibition regulation and memory in mice (full – 2013) http://www.frontiersin.org/Journal/1...013.00149/full
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full – 2013) http://www.plosone.org/article/info%...l.pone.0076635
Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes (full – 2013) http://onlinelibrary.wiley.com/doi/1...cps.12108/full
“Spiceophreniaâ€: a systematic overview of “Spiceâ€-related psychopathological issues and a case report (full – 2013) http://onlinelibrary.wiley.com/doi/1.../hup.2312/full
Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776056/
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717536/
What does a mouse tell us about neuregulin 1-cannabis interactions? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581817/
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23359015
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst – 2013) http://link.springer.com/article/10....213-012-2839-1
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23389966
Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23414608
Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23518784
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://onlinelibrary.wiley.com/doi/1...21640/abstract
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23670023
Peripheral endocannabinoid system dysregulation in first-episode psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23822951
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23800614
Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23846977
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23867051
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23906663
Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24219803
The role of cannabinoid 1 receptor expressing interneurons in behavior (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24239560
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24253425
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
Cannabidiol as a potential treatment for psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24309088
High K2 use rate among psych unit patients (news – 2013) http://www.odt.co.nz/news/national/2...-unit-patients
GABA deficits disturb endocannabinoid system (news – 2013) http://www.sciencecodex.com/read/gab...d_system-84784
Cannabis psychosis admissions rose after drug reclassified to Class B (news – 2013) http://www.guardian.co.uk/science/si...k-drug-class-c
Harvard: Marijuana Doesn’t Cause Schizophrenia (news – 2013) http://psychcentral.com/news/2013/12...nia/63148.html
Can The Cannabis Component Cannabidiol (CBD) Cure Schizophrenia? (news – 2013) http://www.examiner.com/article/can-...ign-right-next
The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24518399
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full – 2014) http://onlinelibrary.wiley.com/doi/1...epi.12631/full
CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain
neurotensin (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016688/
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915876/
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders (full – 2014) http://jpn.ca/wp-content/uploads/201...9-6-140081.pdf
Cannabinoids and schizophrenia: therapeutic prospects (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
A controlled family study of cannabis users with and without psychosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24309013
Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24418217
Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24457285
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853061
Genetic predisposition to schizophrenia associated with increased use of cannabis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24957864
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25138234
Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: A brain stimulation reward study (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25092427
Paranoid Personality Disorder in the United States: The Role of Race, Illicit Drug Use, and Income (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25176118
Cannabis use and suicidal ideations in high-school students (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25253856
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25392292
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25454117
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25510937
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25522381
Risk-taking in schizophrenia and controls with and without cannabis dependence (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25467541
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491
Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25539511
The phytocannabinoid, Δ9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce anti-psychotic effects (abst – 2014) http://onlinelibrary.wiley.com/doi/1...13000/abstract
Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment? (news – 2014) (requires free registration) http://www.fool.com/investing/genera...a-topschi.aspx
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug's harm to children and adults, but the scientific evidence is seldom clear-cut (article – 2015) http://onlinelibrary.wiley.com/doi/1...ncy.21516/full
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25618402
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page – 2015) http://journals.lww.com/psychopharma...elated.14.aspx
Marijuana Could Be the Answer to Fighting These 3 Diseases (news – 2015) (may require free registration) http://www.fool.com/investing/genera...g-these-3.aspx
Cannabis and psychosis: what causes what? (full – 2013)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544398/
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission
Associated with Olanzapine-Induced Weight Gain (full – 2013)
http://www.plosone.org/article/info%...l.pone.0033548
An investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid
receptor stimulation on prepulse inhibition regulation and memory in mice (full – 2013) http://www.frontiersin.org/Journal/1...013.00149/full
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full – 2013) http://www.plosone.org/article/info%...l.pone.0076635
Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes (full – 2013) http://onlinelibrary.wiley.com/doi/1...cps.12108/full
“Spiceophreniaâ€: a systematic overview of “Spiceâ€-related psychopathological issues and a case report (full – 2013) http://onlinelibrary.wiley.com/doi/1.../hup.2312/full
Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776056/
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717536/
What does a mouse tell us about neuregulin 1-cannabis interactions? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581817/
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23359015
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst – 2013) http://link.springer.com/article/10....213-012-2839-1
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23389966
Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23414608
Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23518784
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://onlinelibrary.wiley.com/doi/1...21640/abstract
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23670023
Peripheral endocannabinoid system dysregulation in first-episode psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23822951
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23800614
Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23846977
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23867051
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23906663
Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24219803
The role of cannabinoid 1 receptor expressing interneurons in behavior (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24239560
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24253425
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
Cannabidiol as a potential treatment for psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24309088
High K2 use rate among psych unit patients (news – 2013) http://www.odt.co.nz/news/national/2...-unit-patients
GABA deficits disturb endocannabinoid system (news – 2013) http://www.sciencecodex.com/read/gab...d_system-84784
Cannabis psychosis admissions rose after drug reclassified to Class B (news – 2013) http://www.guardian.co.uk/science/si...k-drug-class-c
Harvard: Marijuana Doesn’t Cause Schizophrenia (news – 2013) http://psychcentral.com/news/2013/12...nia/63148.html
Can The Cannabis Component Cannabidiol (CBD) Cure Schizophrenia? (news – 2013) http://www.examiner.com/article/can-...ign-right-next
The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24518399
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full – 2014) http://onlinelibrary.wiley.com/doi/1...epi.12631/full
CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain
neurotensin (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016688/
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915876/
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders (full – 2014) http://jpn.ca/wp-content/uploads/201...9-6-140081.pdf
Cannabinoids and schizophrenia: therapeutic prospects (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
A controlled family study of cannabis users with and without psychosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24309013
Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24418217
Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24457285
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853061
Genetic predisposition to schizophrenia associated with increased use of cannabis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24957864
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25138234
Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: A brain stimulation reward study (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25092427
Paranoid Personality Disorder in the United States: The Role of Race, Illicit Drug Use, and Income (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25176118
Cannabis use and suicidal ideations in high-school students (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25253856
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25392292
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25454117
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25510937
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25522381
Risk-taking in schizophrenia and controls with and without cannabis dependence (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25467541
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491
Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25539511
The phytocannabinoid, Δ9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce anti-psychotic effects (abst – 2014) http://onlinelibrary.wiley.com/doi/1...13000/abstract
Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment? (news – 2014) (requires free registration) http://www.fool.com/investing/genera...a-topschi.aspx
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug's harm to children and adults, but the scientific evidence is seldom clear-cut (article – 2015) http://onlinelibrary.wiley.com/doi/1...ncy.21516/full
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25618402
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page – 2015) http://journals.lww.com/psychopharma...elated.14.aspx
Marijuana Could Be the Answer to Fighting These 3 Diseases (news – 2015) (may require free registration) http://www.fool.com/investing/genera...g-these-3.aspx